Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 352 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Avera Cancer Sequencing and Analytics Protocol (ASAP)

for
Cancer, Cancer Diagnosis, Early Detection of Cancer,
Location: Marshall MN, Sioux Falls SD, Yankton SD, Mitchell SD,
Sponsor: Avera McKennan Hospital & University Health Center

Sex: All

Age: 18+

Code: NCT05142033

Recruiting

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

for
Ovarian Cancer, Ovarian Carcinoma, Endometrial Cancer,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 18+

Code: NCT06677190

Phase2, Recruiting

Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer

for
Platinum-resistant Ovarian Cancer, Recurrent Ovary Cancer,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18 - 70+

Code: NCT06321484

Phase1, Recruiting

Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer

for
Ovarian Cancer
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: Female

Age: 18 - 70+

Code: NCT01187602

Recruiting

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Montreal, Winston-Salem NC, Pittsburgh PA, Charlotte NC,
Sponsor: Incyte Corporation

Sex: Female

Age: 18+

Code: NCT07214779

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

for
Breast Cancer, Sarcoma, Gastric Cancer, Lung Cancer,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06580002

Phase2, Recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

for
Ovarian Cancer, Ovarian Cancer Recurrent
Location: Boston MA, New York NY, Charlottesville VA,
Sponsor: Compugen Ltd

Sex: Female

Age: 18+

Code: NCT06888921

Phase1, Phase2, Recruiting

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

for
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT01174121

Phase2, Recruiting

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18+

Code: NCT05065021

Phase2, Recruiting

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

for
Breast Cancer, Hereditary Breast and Ovarian Cancer
Location: Lee's Summit MO, Kansas City MO, Kansas City KS,
Sponsor: University of Kansas Medical Center

Sex: All

Age: 0+

Code: NCT02302742

Recruiting

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

for
Malignant Female Reproductive System Neoplasm,
Location: Baltimore MD, Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03968406

Phase1, Recruiting

NYSCF Scientific Discovery Biobank

for
ALS, Amyotrophic Lateral Sclerosis, Alzheimer Disease,
Location: New York NY
Sponsor: New York Stem Cell Foundation Research Institute

Sex: All

Age: 0+

Code: NCT06203106

Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

for
Triple Negative Breast Cancer, Breast Cancer,
Location: Boston MA, New York NY, Fairfax VA, Jacksonville FL,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05377996

Phase1, Phase2, Recruiting

Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies

for
Ovarian Cancer
Location: Albuquerque NM
Sponsor: New Mexico Cancer Research Alliance

Sex: Female

Age: 18+

Code: NCT03943316

Recruiting

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

for
Educational Materials for Genetic Testing, Breast Cancer,
Location: Jamaica NY, Richmond Hill NY, Brooklyn NY, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04751435

Recruiting

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

for
Platinum-resistant Ovarian Cancer, Testicular Cancer,
Location: Boston MA, Providence RI, New York NY, Durham NC,
Sponsor: Context Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06515613

Phase1, Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

for
Non-small Cell Lung Cancer,
Location: Boston MA, New York NY, New Brunswick NJ, Pittsburgh PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05877599

Phase1, Recruiting

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

for
Breast Cancer, Ovarian Cancer
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: Female

Age: 21+

Code: NCT06430541

Phase1, Recruiting

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

for
Colitis, Diarrhea, Malignant Genitourinary System Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04038619

Phase1, Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: 858 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06395519

Phase1, Phase2, Recruiting